We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Hits Teva With Patent Suit Over Hepatitis B Drug Baraclude
BMS Hits Teva With Patent Suit Over Hepatitis B Drug Baraclude
October 12, 2010
Bristol-Myers Squibb (BMS) has filed a patent infringement lawsuit against Teva Pharmaceutical Industries after the generic-drug maker asked the FDA for approval to market a generic version of BMS’ hepatitis B drug Baraclude.